Literature DB >> 15121436

Changing patterns of adult (45-74 years) neurological deaths in the major Western world countries 1979-1997.

C Pritchard1, D Baldwin, A Mayers.   

Abstract

OBJECTIVES: To compare changes in 'adult' (45-74 years) 'all-cause deaths' (ACDs) with all neurological death categories by age and gender in the 10 major Western countries between the 1970s (1979-1981) and the 1990s (1995-1997).
METHOD: World Health Organization standardized mortality data for age and gender (1979/97) were used to examine changes in adult mortality rates per million based upon ICD-9 categories for ACDs, 'neurological deaths' and the special neurological categories of 'other neurological deaths' (ONDs) and 'mental disorder deaths' (MDDs), which include the dementias. Ratios of ratios were calculated to demonstrate how each individual country's pattern changed over the period by age and gender, resolving the problem of cross-national comparisons. Rates of change across the endpoints and between age groups (45-54, 55-64, 65-74 and 75+ years) were examined using analysis of variance, stepwise regression analysis and cross-tabulation analyses.
RESULTS: Meningitis deaths fell substantially, but there was little change in multiple sclerosis or epilepsy deaths. OND rates for the 1990s increased compared with the 1970s rates for males and female, in actual terms and relative to ACDs for almost all countries. Many of the relative rates of increase were substantially higher than 20%. There were significant statistical differences with respect to relative rates of ONDs between the 1970s and the 1990s data, even when the 75+ years age group was excluded. Significant differences were also found between age groups, but only in the 1990s data. MDD rates showed similar trends. Analyses of actual rates of increase in these causes of death showed that males outnumber females in all ages below 74 years. The extent of this difference remained constant across the endpoints. However, in those aged 75 years and over, females outnumbered males at both endpoints, but this disparity widened significantly in the 1990s data.
CONCLUSIONS: The 1990s data indicate substantial increases compared with the 1970s data for ONDs (especially amongst 65-74 year olds), and rises in MDDs in 55-64 year olds in five countries, including England and Wales and Germany, and in 65-74 year olds in most countries, suggesting earlier onsets of the underlying conditions. Further country-specific research is required to explain the emerging morbidity and mortality.

Entities:  

Mesh:

Year:  2004        PMID: 15121436     DOI: 10.1016/j.puhe.2003.07.002

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  5 in total

1.  Meta-analysis of population-based studies comparing risk of cerebrovascular accident associated with first- and second-generation antipsychotic prescribing in dementia.

Authors:  Ahsan Rao; Amna Suliman; Giles Story; Sabine Vuik; Paul Aylin; Ara Darzi
Journal:  Int J Methods Psychiatr Res       Date:  2016-04-27       Impact factor: 4.035

2.  Changes in cancer incidence and mortality in England and Wales and a comparison of cancer deaths in the major developed countries by age and sex 1979-2002 in context of GDP expenditure on health.

Authors:  C Pritchard; T Hickish
Journal:  Ecancermedicalscience       Date:  2008-07-28

3.  Neurological deaths of American adults (55-74) and the over 75's by sex compared with 20 Western countries 1989-2010: Cause for concern.

Authors:  Colin Pritchard; Emily Rosenorn-Lanng
Journal:  Surg Neurol Int       Date:  2015-07-23

4.  The rise of mortality from mental and neurological diseases in Europe, 1979-2009: observational study.

Authors:  Johan P Mackenbach; Marina Karanikolos; Caspar W N Looman
Journal:  BMC Public Health       Date:  2014-08-13       Impact factor: 3.295

5.  Controlled population-based comparative study of USA and international adult [55-74] neurological deaths 1989-2014.

Authors:  C Pritchard; E Rosenorn-Lanng; A Silk; L Hansen
Journal:  Acta Neurol Scand       Date:  2017-06-18       Impact factor: 3.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.